Carcinoma, Transitional Cell: all 725 studies
Page 1 of 8. Open to participants first (201), then studies with results posted, then the rest; newest registration first within each.
- Urinary Cell-Free DNA Liquid Biopsy for Urothelial Cancer Diagnosis and Origin IdentificationRecruitingNCT07888374
- Perioperative Systemic Therapies in Muscle-Invasive Bladder Cancer (GUARDIANS)RecruitingNCT07855926
- Trop2-Targeted NIR-II Fluorescent Probe for Identifying Bladder Cancer in Ex Vivo Bladder SamplesRecruitingNCT07848854Phase 2
- A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid TumorsNot yet recruitingNCT07837622Phase 2
- A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial CarcinomaRecruitingNCT07815665Phase 2/3
- Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or MetastaticRecruitingNCT07807345Phase 1
- Prospective Collection And Molecular Analysis Of Biospecimens And Clinical Data From Patients With Urothelial Carcinoma And Related Malignancies Of The Urinary TractRecruitingNCT07789119
- Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial CancerRecruitingNCT07756437
- A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsRecruitingNCT07749586Phase 1/2
- RESTORE-BLADDER (REgistry on STrategies for Organ pREservation in Muscle-invasive BLADDER Cancer)Not yet recruitingNCT07744958
- An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUCRecruitingNCT07720284Phase 3
- Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder CancerRecruitingNCT07717242Phase 2
- FAPI PET Imaging - An Exploratory StudyNot yet recruitingNCT07705074Phase 1/2
- DBC-664 in Adult Patients With Solid TumorsRecruitingNCT07705035Phase 1
- Expanded Access for Vepugratinib (LY3866288) in Participants With Fibroblast Growth Factor Receptor 3 (FGFR3) Altered Solid TumorsAvailableNCT07675057
- Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder CancerRecruitingNCT07673016
- Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLCRecruitingNCT07671092Early Phase 1
- Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma (FUSCC-SPARE-UC-01)Not yet recruitingNCT07662863Phase 2
- EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBCRecruitingNCT07647289Phase 2
- Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial CarcinomaNot yet recruitingNCT07643519Phase 2
- A Phase II Study of AK146D1 Mono or Combined With AK112 in Advanced Urothelial CarcinomaNot yet recruitingNCT07636772Phase 2
- Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid TumorNot yet recruitingNCT07631884Phase 2
- An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard TherapyNot yet recruitingNCT07631871Phase 2
- Study of Peripheral Neuropathy in Patients With Advanced Urothelial Cancer Treated With Enfortumab Vedotin and Pembrolizumab With Supportive Neuridase (ENDEAVOR)Not yet recruitingNCT07629700Not applicable
- Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid TumorsRecruitingNCT07628634Early Phase 1
- A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT07623369Phase 1
- Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma DiagnosisRecruitingNCT07614594
- Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer StagingRecruitingNCT07602010
- Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBTRecruitingNCT07589413
- Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialNot yet recruitingNCT07576725Phase 2
- Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)RecruitingNCT07566156Phase 3
- 18F-T2 PET/CT Imaging for CAIX Positive Solid TumorsRecruitingNCT07557225Not applicable
- Calcium Electroporation for Urinary Bladder Tumors: A First-in-Human Feasibility, Safety, and Early Response TrialNot yet recruitingNCT07555769Phase 1
- A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor CancerRecruitingNCT07532902Phase 1
- SYS6002 vs Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial CarcinomaNot yet recruitingNCT07526792Phase 3
- Immune-Stromal Landscape in Muscle-Invasive Bladder CancerNot yet recruitingNCT07525349
- A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid TumorsRecruitingNCT07518043Phase 1
- Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard TherapyRecruitingNCT07506057Phase 2
- Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial CarcinomaRecruitingNCT07492628Phase 1
- Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 InhibitorsRecruitingNCT07485114
- Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial CancerRecruitingNCT07484022Phase 1
- Maintenance AVElumab After SECond Line Platinum-based Chemotherapy for Metastatic Urothelial CarcinomaNot yet recruitingNCT07460245Phase 2
- Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology OmicsEnrolling by invitationNCT07454941
- Korean Prospective Upper Tract Urothelial Carcinoma CohortRecruitingNCT07452432
- Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial CarcinomaRecruitingNCT07441499
- Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid TumorsRecruitingNCT07439120Early Phase 1
- Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial CancerRecruitingNCT07421700Phase 1/2
- A Study of GEN1106 in Participants With Solid TumorsRecruitingNCT07416123Phase 1
- Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomARecruitingNCT07413523Not applicable
- A Study of Ward Admissions for HaematuriaRecruitingNCT07395037
- A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial CarcinomaRecruitingNCT07393542Phase 3
- A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial CarcinomaRecruitingNCT07390617
- Criteria for Selecting First-line Metastatic Treatment for Patients With Urothelial CarcinomaRecruitingNCT07339878
- Olfactive Detection of Urothelial Carcinoma by Sniffer DogsRecruitingNCT07334314
- Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid TumorsRecruitingNCT07334119Phase 1
- Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBCRecruitingNCT07322263Phase 2
- 9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial CancerRecruitingNCT07314723Phase 2
- A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsRecruitingNCT07287995Phase 1/2
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
- A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsRecruitingNCT07277413Phase 1
- Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)RecruitingNCT07241793Phase 2
- Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical CystectomyRecruitingNCT07234968Not applicable
- Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial CarcinomaRecruitingNCT07221942Phase 2
- A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary TractRecruitingNCT07218380Phase 3
- N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial CancerNot yet recruitingNCT07217496Phase 1
- Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 StudyNot yet recruitingNCT07189793Phase 2
- Circulating Tumor DNA Response In Urothelial CancerRecruitingNCT07183319Phase 2
- A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid TumorsRecruitingNCT07169734Phase 1/2
- Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcinoma PatientsRecruitingNCT07164950Not applicable
- Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial CarcinomaRecruitingNCT07129993Phase 2/3
- Supporting Sexual Recovery in Women With Bladder CancerEnrolling by invitationNCT07091565
- A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsRecruitingNCT07090499Phase 1
- Neurological Function in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin-Based TherapyNot yet recruitingNCT07072637
- Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial CarcinomaRecruitingNCT07043972Phase 2
- Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed?RecruitingNCT07037589
- The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive MalignanciesEnrolling by invitationNCT07023861Early Phase 1
- PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant TumorsEnrolling by invitationNCT07023848Early Phase 1
- A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory CarcinomasRecruitingNCT06999187Phase 1
- A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)RecruitingNCT06991868
- Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial CarcinomaRecruitingNCT06983210Phase 2
- A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial CarcinomaRecruitingNCT06982794
- Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic CancersRecruitingNCT06967961Not applicable
- Study of DCC-2812 in Participants With Advanced Genitourinary CancersRecruitingNCT06966024Phase 1
- A Study of MT-4561 in Patients With Various Advanced Solid TumorsRecruitingNCT06943521Phase 1/2
- Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial CarcinomaNot yet recruitingNCT06927128Phase 2
- Performance Evaluation of a Urine-based Methylation Assay for Urothelial CarcinomaNot yet recruitingNCT06912672
- Probiotics in Advanced Urothelial CarcinomaRecruitingNCT06904573Phase 2
- JAM3 as a Prognostic Biomarker in Muscle-Invasive Urothelial Carcinoma: Correlation With Therapeutic Response, and Survival OutcomesNot yet recruitingNCT06901934
- A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial CancerRecruitingNCT06862219Phase 4
- Trop2-targeted immunoPET Imaging of Solid TumorsRecruitingNCT06851663Phase 2/3
- 9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial CarcinomaRecruitingNCT06823427Phase 2
- HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort StudyNot yet recruitingNCT06798246
- A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial CancerRecruitingNCT06774131Phase 3
- Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.RecruitingNCT06724159
- PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial CarcinomaRecruitingNCT06696742Phase 2
- A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsRecruitingNCT06695845Phase 2
- Ivonescimab in the Treatment of Multiple Advanced TumorsRecruitingNCT06683846Phase 2
- Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk RecurrenceRecruitingNCT06682728Phase 2
- Predictive Role of Microbiome in Patients With Urothelial CarcinomaNot yet recruitingNCT06675656
- Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic or Locally Advanced Urothelial CarcinomaRecruitingNCT06657157